We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026

Dade Behring to Develop Cardiac Marker Tests

By HospiMedica staff writers
Posted on 07 Dec 2004
Certain semi-exclusive diagnostic rights for the commercialization of automated diagnostic tests using myeloperoxidase (MPO) have been granted to Dade Behring (Deerfield, IL, USA) by The Cleveland Clinic (OH, USA).

According to research conducted at The Cleveland Clinic, MPO testing may be particularly beneficial in patients with chest pain who exhibit low initial troponin (a) levels, usually an indication that no heart muscle cells have died. More...
In this case, the presence of an elevated MPO level has been linked to risk for subsequent cardiac events. Therefore, a simple MPO blood test has the potential to help doctors identify patients at risk of subsequent heart attack and refer them for treatment prior to the occurrence of heart damage.

Researchers at the Cleveland Clinic investigated initial MPO levels in more than 600 patients in the emergency room complaining of chest pain. By using an MPO blood test in addition to laboratory-based risk assessments, they increased their ability to identify patients who would have heart problems during the next 30 days to six months from 54% to 85%. A larger study in Europe has confirmed these results.

"The potential of a simple blood test to help identify patients at particular risk of heart damage is very exciting,” commented Eric J. Topol, M.D., chairman of The Cleveland Clinic's department of cardiovascular medicine. "We need to build on the great success of the troponin test in changing medicine, and the MPO test may be a way to do that.”





Related Links:
Dade Behring
Cleveland Clinic

Gold Member
12-Channel ECG
CM1200B
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Digital Radiography System (Ceiling Free)
Digix CF Series
New
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.